APTO - Aptose Biosciences Inc.
IEX Last Trade
0.2115
0.000 0.142%
Share volume: 695,807
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$0.21
-0.01
-0.04%
Summary score
8%
Profitability
8%
Dept financing
22%
Liquidity
24%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.07%
Return on assets
-41.95%
Return on sales
0%
Return on invested capital
364.01%
Total debt ratio
57.66%
Debt ratio change over timeo
-0.82%
Current Ratio
5.92%
Quick Ratio
0%
Cash Position Ratio
3.85%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-75.11%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
131.18%
Debt ratio change over timeo
-0.59%
Current Ratio
0.9%
Quick Ratio
0%
Cash Position Ratio
0.67%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-76.28%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
98.93%
Debt ratio change over time
-0.69%
Current Ratio
0.97%
Quick Ratio
0%
Cash Position Ratio
0.61%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-103.72%
Return on assets
-112.94%
Return on sales
0%
Return on invested capital
-10.18%
Total debt ratio
-82.08%
Debt ratio change over time
-0.82%
Current Ratio
0.64%
Quick Ratio
0%
Cash Position Ratio
0.06%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | APTO | ABBV | AMGN | VRTX |
---|---|---|---|---|
Return on equity | -15.07% | 13.03% | 18.15% | 6.63% |
Return on assets | -41.95% | 2.28% | 3.22% | 5.84% |
Return on sales | 0% | 27.95% | 31.46% | 43.41% |
Return on invested capital | 364.01% | 2.07% | 5.53% | 34.89% |
Profitability | 25% | 44% | 57% | 62% |
Total debt ratio | 57.66% | 91.02% | 90.77% | 24.67% |
Debt ratio change over time | -0.82% | 435.59% | 17.23% | -0.06% |
Dept financing | 16% | 50% | 26% | 7% |
Current Ratio | 0.9% | 0.82% | 1.41% | 3.64% |
Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
Cash Position Ratio | 0.67% | 0.31% | 0.49% | 2.77% |
Liquididy | 50% | 10% | 23% | 64% |
Short-term ratios | APTO | ABBV | AMGN | VRTX |
---|---|---|---|---|
Return on equity | 0% | 0% | 0% | 5.91% |
Return on assets | -75.11% | 1.6% | 2.14% | 4.97% |
Return on sales | 0% | 24.8% | 18.91% | 42.59% |
Return on invested capital | 0% | 0% | 0% | 23.7% |
Profitability | 0% | 23% | 22% | 100% |
Total debt ratio | 131.18% | 94.49% | 93.35% | 24.56% |
Debt ratio change over time | -0.59% | 0% | 0% | -0.62% |
Dept financing | 25% | 18% | 43% | 5% |
Current Ratio | 0.9% | 0.82% | 1.41% | 3.64% |
Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
Cash Position Ratio | 0.67% | 0.31% | 0.49% | 2.77% |
Liquididy | 12% | 14% | 21% | 75% |